The effect of epigenetic changes on the genetic landscapes of HCC is further illustrated by the association between CLDme score and the overall tumour mutational burden and TP53 mutations in HCC, suggesting that the epigenetic state when a driver gene mutation occurs may influence outcome. Here, TP53 is linked to neoplasm.